AstraZeneca vaccine more than 90pc effective against COVID-19 variants first identified in India

What the vaccine offers: The AstraZeneca COVID-19 vaccine is found to be more than 90pc effective against hospitalisation from Delta and Kappa variants. Details: The Delta and Kappa variants were first identified in India which have caused more than 180,000 deaths in the vicious second-wave. New deadlier variant: India’s health ministry on Tuesday declared a new coronavirus variant “Delta Plus” to be of concern. Click here for more from Propergaanda.